CareQuest Innovation Partners
Corporate VCLate Stage
Investment thesis
CareQuest Innovation Partners addresses a critical gap in oral health innovation and funding. The firm recognizes that oral health is underserved in venture capital, with digital dental health startups receiving less than 2% of digital health funding despite the $54 billion oral health prevention market. The firm focuses on transforming oral health and overall health outcomes by funding solutions in teledentistry, medical-dental integration, pediatric care, and maternal health. Operating as a for-profit arm of a national nonprofit focused on health care accessibility and equity, the firm combines commercial investment with mission-driven impact.
Source: firm website, verified Jul 21, 2026.
Frequently asked questions
- What stage does CareQuest Innovation Partners invest at?
- CareQuest Innovation Partners invests at the Late Stage stage.
- What sectors does CareQuest Innovation Partners focus on?
- CareQuest Innovation Partners focuses on Digital Health, Healthtech, Medical Devices.
From the blog
visit blog ↗CareQuest Innovation Partners has been advancing medical-dental integration and preventive oral health initiatives through its SMILE Health accelerator and ACCELERATE program, with recent wins including a pilot demonstrating significant increases in early childhood dental visits. AI summary
Images
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.
EQT Life Sciences is one of Europe's largest and most experienced life sciences investors, focusing on innovative companies developing therapeutics, medical devices, diagnostics, and healthtech globally. The firm has raised approximately 3.5 billion euros across 12 private funds and 3 investment strategies over its 30-year history.